Ferring Urology-Oncology portfolio distribution agreement with Cipla Australia

The Society has been informed that Ferring Pharmaceuticals has finalised an agreement with Cipla Limited to exclusively market, distribute and support the use of Ferring’s existing Urology-oncology drug portfolio in Australia.

Access the announcement: Ferring Urology-Oncology portfolio distribution agreement with Cipla Australia Pty Ltd.